— Know what they know.
Not Investment Advice

KPTI NASDAQ

Karyopharm Therapeutics Inc.
1W: -50.5% 1M: -55.2% 3M: -91.7% YTD: -88.8% 1Y: -87.1% 3Y: -96.1% 5Y: -99.1%
$0.80
-0.06 (-7.45%)
 
Weekly Expected Move ±20.4%
$0 $1 $1 $1 $1
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 33 · $18.2M mcap · 15M float · 8.60% daily turnover · Short 43% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
41.8 / 100
NoneWeakNarrowWide
Primary source: Cost Advantage  ·  ROIC: 36.3%
Cost Advantage ★
59
Intangibles
45
Switching Cost
30
Network Effect
48
Scale
27
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. KPTI shows a Weak competitive edge (41.8/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Cost Advantage. ROIC of 36.3% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$0
Low
$7
Avg Target
$14
High
Based on 12 analyst ratings (12 mo)
Analyst Recommendations
Strong Buy: 0Buy: 13Hold: 5Sell: 2Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$7.33
Analysts3
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-07-31 H.C. Wainwright Robert Burns $13 $3 -10 -57.2% $7.01
2026-07-31 Robert W. Baird — $21 $3 -18 -57.2% $7.01
2026-07-21 RBC Capital Brian Abrahams $19 $16 -3 +97.3% $8.11
2026-05-06 H.C. Wainwright — $15 $13 -2 +38.2% $9.41
2026-04-27 Piper Sandler — $12 $16 +4 +84.8% $8.66
2026-03-09 UBS — Initiated $28 — +229.8% $8.49
2025-12-17 Piper Sandler — Initiated $12 — +89.6% $6.33
2025-11-04 RBC Capital Brian Abrahams $3 $19 +16 +239.3% $5.60
2025-10-13 H.C. Wainwright Robert Burns Initiated $15 — +172.7% $5.50
2025-10-09 Robert W. Baird — $14 $21 +7 +255.9% $5.90
2025-10-08 Leerink Partners — $5 $6 +1 +1.5% $5.91
2024-06-10 RBC Capital Brian Abrahams $8 $3 -5 +215.4% $0.95
2023-01-09 Leerink Partners — Initiated $5 — +76.1% $2.84
2022-08-23 Robert W. Baird Collen Kusy Initiated $14 — +151.8% $5.56
2022-03-09 RBC Capital Brian Abrahams Initiated $8 — +23.3% $6.49

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B-
Oct 02, 2026
DCF
5
ROE
5
ROA
1
D/E
1
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. KPTI receives an overall rating of B-. Strongest factors: DCF (5/5), ROE (5/5). Areas of concern: ROA (1/5), D/E (1/5), P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-08-04 C+ B-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 15 Grade D
Profitability
20
Balance Sheet
33
Earnings Quality
22
Growth
38
Value
15
Momentum
39
Safety
0
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. KPTI scores highest in Momentum (39/100) and lowest in Safety (0/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-27.07
Distress Zone
Piotroski F-Score
2/9
✗ ✗ ✗ ✓ ✗ ✗ ✗ ✗ ✓
Beneish M-Score
-9.51
Unlikely Manipulator
Ohlson O-Score
19.28
Bankruptcy prob: 100.0%
High Risk
Credit Rating
CCC
Score: 14.9/100
Trend: Deteriorating
Earnings Quality
—
OCF/NI: 0.29x
Accruals: -147.5%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. KPTI scores -27.07, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. KPTI scores 2/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. KPTI's score of -9.51 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. KPTI's implied 100.0% bankruptcy probability signals significant financial distress. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. KPTI receives an estimated rating of CCC (score: 14.9/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-0.04x
PEG
0.00x
P/S
0.12x
P/B
-0.07x
P/FCF
-4.33x
P/OCF
—
EV/EBITDA
-2.46x
EV/Revenue
2.96x
EV/EBIT
-2.46x
EV/FCF
-6.63x
Earnings Yield
-79.49%
FCF Yield
-23.11%
Shareholder Yield
0.00%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. KPTI currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.000
NI / EBT
×
Interest Burden
1.277
EBT / EBIT
×
EBIT Margin
-1.200
EBIT / Rev
×
Asset Turnover
1.356
Rev / Assets
×
Equity Multiplier
-0.380
Assets / Equity
=
ROE
79.0%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. KPTI's ROE of 79.0% is driven by Asset Turnover (1.356), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$0.80
Median 1Y
$0.23
5th Pctile
$0.04
95th Pctile
$1.28
Ann. Volatility
103.5%
Analyst Target
$7.33
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Richard Paulson
President and Chief Executive Officer
$770,000 $838,996 $2,320,902
Reshma Rangwala Medical
edical Officer and Head of Research
$567,736 $79,492 $2,016,134
Stuart Poulton President,
Vice President, Chief Development Officer
$500,135 $312,293 $1,399,580

CEO Pay Ratio

5:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $2,320,902
Avg Employee Cost (SGA/emp): $461,439
Employees: 228

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
228
-18.3% YoY
Revenue / Employee
$640,645
Rev: $146,067,000
Profit / Employee
$-859,820
NI: $-196,039,000
SGA / Employee
$461,439
Avg labor cost proxy
R&D / Employee
$550,952
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE 9.8% 8.5% 1.8% 1.0% 66.2% 3.4% 2.5% 1.5% 1.2% 1.9% 1.4% 88.4% 67.3% 47.4% 33.4% 66.6% 58.1% 81.9% 82.7% 79.0% 78.98%
ROA -69.7% -40.1% -38.0% -38.1% -36.3% -49.8% -51.0% -51.1% -55.8% -47.8% -55.2% -35.1% -38.1% -37.8% -37.6% -77.5% -87.2% -1.4% -1.5% -2.1% -2.08%
ROIC 96.5% 60.8% 58.8% 54.7% 44.4% 97.2% 86.2% 76.1% 75.7% 67.9% 74.1% 1.2% 1.0% 94.2% 1.1% 91.0% 69.3% 58.2% 53.0% 36.3% 36.27%
ROCE -97.5% -42.2% -35.2% -38.3% -35.9% -47.9% -50.6% -49.3% -55.8% -69.6% -87.7% -40.0% -42.8% -54.0% -53.5% -13.9% -8.9% -9.2% -10.5% 7.7% 7.68%
Gross Margin 98.4% 99.4% 97.0% 97.6% 97.3% 94.4% 96.5% 96.8% 97.5% 95.4% 94.0% 96.4% 96.6% 95.6% 95.7% 97.2% 95.2% 95.6% 96.1% 96.8% 96.75%
Operating Margin -1.2% 37.2% -72.6% -1.1% -85.3% -1.0% -79.8% -78.7% -86.8% -1.1% -1.0% -65.7% -67.8% -1.0% -1.1% -64.3% -34.6% -52.4% -76.3% -67.4% -67.38%
Net Margin -1.4% 30.7% -86.8% -1.2% -1.0% -1.1% -88.2% -86.8% -95.8% -1.2% -1.1% 55.6% -82.7% -1.0% -78.2% -98.2% -75.2% -3.0% -63.9% -2.0% -2.00%
EBITDA Margin -1.2% 37.0% -72.2% -1.1% -83.0% -96.6% -72.4% -70.9% -78.7% -1.0% -94.6% 76.9% -53.1% -64.2% -41.2% -68.3% -51.2% -2.6% -28.0% -1.6% -1.61%
FCF Margin -1.4% -51.2% -48.5% -37.1% -39.1% -95.2% -73.8% -68.3% -69.2% -63.5% -83.8% -89.6% -81.1% -87.9% -86.3% -75.0% -62.7% -51.6% -39.1% -44.6% -44.57%
OCF Margin -1.4% -51.1% -48.4% -36.9% -38.9% -95.2% -73.8% -68.4% -69.2% -63.5% -83.7% -89.5% -81.0% -87.8% -86.4% -75.0% -62.7% -51.6% -39.1% -44.6% -44.57%
ROA 3Y Avg snapshot only -1.21%
ROIC Economic snapshot only 55.50%
Cash ROA snapshot only -58.70%
NOPAT Margin snapshot only -44.37%
Pretax Margin snapshot only -1.53%
R&D / Revenue snapshot only 83.17%
SGA / Revenue snapshot only 69.55%
SBC / Revenue snapshot only 6.03%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio -31.94 -67.42 -79.24 -52.04 -74.59 -27.75 -2.79 -21.66 -1.10 -0.69 -1.19 -1.49 -1.19 -1.11 -0.51 -0.30 -0.45 -0.67 -0.71 -1.26 -0.036
P/S Ratio 55.52 39.87 36.56 21.44 26.30 29.20 2.98 21.00 1.05 0.68 1.24 0.92 0.70 0.59 0.22 0.27 0.40 0.91 0.91 1.93 0.124
P/B Ratio -52.29 -105.00 -103.08 -46.32 -46.83 -275.37 -9.77 -43.04 -1.53 -0.73 -1.03 -1.01 -0.65 -0.46 -0.15 -0.16 -0.21 -0.45 -0.52 -0.86 -0.070
P/FCF -40.33 -77.95 -75.31 -57.87 -67.33 -30.66 -4.04 -30.73 -1.52 -1.07 -1.48 -1.03 -0.86 -0.67 -0.26 -0.36 -0.63 -1.76 -2.33 -4.33 -4.327
P/OCF — — — — — — — — — — — — — — — — — — — — —
EV/EBITDA -36.53 -85.77 -107.46 -73.22 -109.65 -32.22 -2.71 -25.69 -1.06 -0.72 -1.66 -2.85 -3.02 -4.43 -7.56 -2.24 -2.58 -2.01 -1.88 -2.46 -2.465
EV/Revenue 55.33 39.64 36.45 21.48 26.43 28.57 2.43 20.60 0.84 0.58 1.44 1.22 1.11 1.18 1.04 1.28 1.45 2.07 1.84 2.96 2.957
EV/EBIT -36.35 -85.07 -106.48 -72.58 -108.49 -32.07 -2.69 -25.54 -1.06 -0.71 -1.66 -2.84 -3.00 -4.39 -7.43 -2.24 -2.57 -2.01 -1.87 -2.46 -2.463
EV/FCF -40.19 -77.50 -75.09 -57.97 -67.65 -30.00 -3.29 -30.14 -1.21 -0.92 -1.72 -1.36 -1.37 -1.34 -1.21 -1.71 -2.32 -4.01 -4.70 -6.63 -6.634
Earnings Yield -3.1% -1.5% -1.3% -1.9% -1.3% -3.6% -35.8% -4.6% -91.2% -1.4% -83.9% -67.1% -84.3% -89.8% -2.0% -3.3% -2.2% -1.5% -1.4% -79.5% -79.49%
FCF Yield -2.5% -1.3% -1.3% -1.7% -1.5% -3.3% -24.7% -3.3% -65.8% -93.4% -67.5% -97.5% -1.2% -1.5% -3.9% -2.8% -1.6% -57.0% -42.9% -23.1% -23.11%
PEG Ratio snapshot only 0.000
EV/Gross Profit snapshot only 3.084
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 3.51 3.74 4.17 3.88 3.61 5.31 5.17 4.94 4.24 3.37 3.04 3.62 3.00 1.70 1.33 0.99 1.03 1.12 1.08 0.79 0.792
Quick Ratio 3.45 3.68 4.11 3.82 3.54 5.25 5.11 4.88 4.19 3.32 2.99 3.56 2.93 1.64 1.28 0.94 0.98 1.08 1.05 0.76 0.763
Debt/Equity -1.44 -2.27 -2.17 -1.55 -1.28 -10.75 -3.95 -2.50 -1.77 -1.30 -1.04 -1.48 -1.22 -1.05 -0.91 -0.80 -0.73 -0.80 -0.87 -0.65 -0.654
Net Debt/Equity — — — — — — — — — — — — — — — — — — — — —
Debt/Assets 0.71 0.59 0.61 0.70 0.78 0.50 0.55 0.60 0.66 0.74 0.86 0.91 1.03 1.18 1.46 1.82 2.04 2.15 1.76 1.94 1.939
Debt/EBITDA -1.01 -1.86 -2.27 -2.44 -2.98 -1.29 -1.34 -1.52 -1.54 -1.49 -1.45 -3.15 -3.57 -5.04 -9.51 -2.43 -2.44 -1.55 -1.56 -1.23 -1.227
Net Debt/EBITDA 0.13 0.50 0.32 -0.12 -0.52 0.71 0.62 0.50 0.27 0.12 -0.23 -0.70 -1.12 -2.22 -5.95 -1.77 -1.87 -1.13 -0.95 -0.86 -0.857
Interest Coverage -7.17 -3.75 -2.90 -2.57 -2.25 -5.60 -5.55 -5.00 -4.94 -4.99 -5.10 -2.31 -1.69 -1.04 -0.47 -1.76 -1.82 -3.29 -3.12 -3.57 -3.568
Equity Multiplier -2.02 -3.83 -3.54 -2.20 -1.65 -21.50 -7.21 -4.18 -2.69 -1.77 -1.21 -1.62 -1.19 -0.88 -0.62 -0.44 -0.36 -0.37 -0.49 -0.34 -0.337
Cash Ratio snapshot only 0.485
Debt Service Coverage snapshot only -3.566
Cash to Debt snapshot only 0.302
FCF to Debt snapshot only -0.303
Defensive Interval snapshot only 155.5 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.40 0.68 0.82 0.93 1.03 0.47 0.48 0.53 0.58 0.49 0.53 0.57 0.65 0.72 0.86 0.86 1.00 1.07 1.17 1.36 1.356
Inventory Turnover 1.25 1.01 1.11 1.00 1.00 1.25 1.33 1.51 1.45 1.38 1.72 1.69 1.65 1.59 1.46 1.18 1.34 1.36 1.44 1.34 1.344
Receivables Turnover 7.96 11.86 10.94 12.15 10.81 4.51 4.92 5.24 4.46 3.94 4.24 4.15 4.26 5.03 4.29 3.87 4.48 5.13 5.16 4.67 4.669
Payables Turnover 2.25 1.12 1.20 1.85 4.83 2.38 0.82 2.71 6.06 1.70 0.80 2.37 1.91 1.50 1.01 1.85 1.04 1.31 1.18 1.18 1.178
DSO 46 31 33 30 34 81 74 70 82 93 86 88 86 73 85 94 82 71 71 78 78.2 days
DIO 293 362 327 364 366 292 274 242 252 264 213 216 221 230 251 310 272 269 254 272 271.6 days
DPO 162 325 304 198 76 153 443 135 60 214 453 154 191 243 362 198 352 279 309 310 310.0 days
Cash Conversion Cycle 176 68 57 197 324 219 -96 177 274 142 -155 151 116 59 -27 207 2 61 17 40 39.8 days
Fixed Asset Turnover snapshot only 33.675
Operating Cycle snapshot only 349.7 days
Cash Velocity snapshot only 2.252
Capital Intensity snapshot only 0.759
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 30.3% 94.1% 1.1% 1.5% 1.1% -25.1% -36.8% -41.9% -41.6% -7.0% -5.2% -0.2% 1.8% -0.5% 1.2% -5.8% -4.0% 0.6% 6.3% 6.8% 6.81%
Net Income -2.3% 36.8% 46.2% 50.2% 57.3% -33.2% -46.2% -36.7% -58.7% 13.4% 7.4% 36.5% 37.4% 46.6% 57.3% -37.4% -42.5% -1.6% -2.1% -81.9% -81.88%
EPS 93.4% 46.3% 48.3% 53.0% 59.8% -28.7% -14.0% 4.6% -15.7% -9.2% 9.0% -6.0% 42.7% 51.3% 61.2% -64.1% -37.0% -19.7% -6.9% 45.8% 45.82%
FCF 3.4% 33.1% 32.4% 49.3% 40.3% -39.4% 3.9% -7.2% -3.4% 38.0% -7.8% -30.8% -19.4% -37.6% -4.2% 21.2% 25.9% 40.9% 51.8% 36.5% 36.49%
EBITDA -3.6% 42.2% 54.2% 59.6% 66.5% -43.6% -67.3% -58.8% -91.8% 15.0% 8.4% 46.9% 52.9% 67.4% 83.9% -26.1% -47.8% -2.9% -6.5% -1.2% -1.24%
Op. Income -2.4% 42.8% 54.5% 59.9% 66.3% -44.7% -72.1% -68.4% -1.0% 8.9% 4.4% -4.6% -0.3% 7.8% 10.2% 12.0% 17.3% 24.1% 29.2% 28.5% 28.52%
OCF Growth snapshot only 36.52%
Asset Growth snapshot only 6.14%
Debt Growth snapshot only 13.26%
Shares Change snapshot only 2.36%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y 55.3% 90.5% 1.3% 1.9% 1.2% 56.6% 36.0% 20.8% 17.0% 10.6% 7.5% 12.5% 7.8% -11.5% -15.3% -18.3% -17.1% -2.4% 0.7% 0.1% 0.14%
Revenue 5Y 2.9% 3.2% 3.0% 3.3% 3.6% 1.5% 66.6% 36.0% 35.7% 36.9% 47.0% 70.6% 45.2% 28.9% 19.3% 10.6% 9.4% 6.2% 5.9% 7.5% 7.47%
EPS 3Y — — — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 3Y — — — — — — 69.9% 21.0% 16.9% 10.2% 6.9% 12.2% 7.3% -12.3% -16.0% -18.9% -17.7% -2.6% 0.5% -0.0% -0.01%
Gross Profit 5Y — — — — — — — — — — — — — — 36.2% 10.8% 9.2% 5.9% 5.6% 7.3% 7.32%
Op. Income 3Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — — — — — — — — — —
FCF 5Y — — — — — — — — — — — — — — — — — — — — —
OCF 3Y — — — — — — — — — — — — — — — — — — — — —
OCF 5Y — — — — — — — — — — — — — — — — — — — — —
Assets 3Y 4.9% -3.6% 0.8% 2.5% -8.1% 6.7% -7.8% -7.8% -7.2% -8.4% -9.4% -9.3% -9.3% -18.6% -24.3% -25.8% -25.3% -32.9% -26.1% -28.0% -27.97%
Assets 5Y 6.7% 11.1% 13.6% 6.7% 7.1% 14.7% 17.4% 3.0% 4.2% -6.8% -6.6% -2.1% -8.6% -11.0% -21.0% -22.7% -22.2% -19.1% -13.7% -17.2% -17.23%
Equity 3Y — — — — — — — — — — — — — — — — — — — — —
Book Value 3Y — — — — — — — — — — — — — — — — — — — — —
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.83 0.80 0.80 0.78 0.83 0.80 0.70 0.59 0.61 0.55 0.43 0.42 0.40 0.27 0.11 0.02 0.02 0.45 0.68 0.60 0.600
Earnings Stability 0.85 0.16 0.03 0.02 0.00 0.00 0.06 0.15 0.26 0.40 0.46 0.75 0.70 0.70 0.58 0.53 0.49 0.04 0.03 0.01 0.008
Margin Stability 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.76 0.99 0.99 0.99 0.99 1.00 0.997
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.00 0.50 0.00 0.00 0.50 1.00 0.50 0.500
Earn. Growth Consistency 0.00 1.00 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.99 0.85 0.82 0.50 0.50 0.87 0.82 0.85 0.50 0.95 0.97 0.85 0.85 0.81 0.50 0.85 0.83 0.50 0.50 0.50 0.500
Earnings Smoothness — — — — — — — — — — — — — — — — — — — — —
ROE Trend — — — — — — — — — — — — — — — — — — — — —
Gross Margin Trend 2.25 0.81 0.25 0.02 0.02 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.02 -0.02 -0.01 -0.00 0.00 -0.00 -0.00 -0.00 -0.00 -0.002
FCF Margin Trend 3.92 2.57 1.70 1.50 1.23 0.05 0.25 0.40 0.19 0.10 -0.23 -0.37 -0.27 -0.09 -0.08 0.04 0.13 0.24 0.46 0.38 0.377
Sustainable Growth Rate — — — — — — — — — — — — — — — — — — — — —
Internal Growth Rate — — — — — — — — — — — — — — — — — — — — —
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 0.79 0.86 1.05 0.90 1.10 0.90 0.69 0.71 0.72 0.65 0.80 1.45 1.37 1.67 1.96 0.83 0.72 0.38 0.30 0.29 0.291
FCF/OCF 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
FCF/Net Income snapshot only 0.291
CapEx/Revenue 0.1% 0.1% 0.1% 0.1% 0.1% 0.0% 0.0% 0.0% 0.1% 0.0% 0.1% 0.1% 0.1% 0.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
CapEx/Depreciation snapshot only 0.000
Accruals Ratio -0.15 -0.05 0.02 -0.04 0.04 -0.05 -0.16 -0.15 -0.15 -0.17 -0.11 0.16 0.14 0.25 0.36 -0.13 -0.25 -0.88 -1.05 -1.47 -1.475
Sloan Accruals snapshot only -0.246
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — — — — — — — — — — — — — — —
FCF Payout Ratio — — — — — — — — — — — — — — — — — — — — —
Total Payout Ratio — — — — — — — — — — — — — — — — — — — — —
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield 0.0% 0.0% 0.0% 0.0% -0.1% -3.5% -36.4% -5.2% -1.0% 0.0% 0.0% -0.6% -0.7% -0.9% -2.4% -1.0% 0.0% -6.9% -43.1% -21.1% -21.08%
Total Shareholder Return 0.0% 0.0% 0.0% 0.0% -0.1% -3.5% -36.4% -5.2% -1.0% 0.0% 0.0% -0.6% -0.7% -0.9% -2.4% -1.0% 0.0% -6.9% -43.1% -21.1% -21.08%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Interest Burden (EBT/EBIT) 1.14 1.27 1.34 1.39 1.44 1.18 1.18 1.20 1.20 1.20 1.20 1.43 1.59 1.96 3.13 1.57 1.54 1.30 1.32 1.28 1.277
EBIT Margin -1.52 -0.47 -0.34 -0.30 -0.24 -0.89 -0.90 -0.81 -0.80 -0.81 -0.87 -0.43 -0.37 -0.27 -0.14 -0.57 -0.57 -1.03 -0.98 -1.20 -1.200
Asset Turnover 0.40 0.68 0.82 0.93 1.03 0.47 0.48 0.53 0.58 0.49 0.53 0.57 0.65 0.72 0.86 0.86 1.00 1.07 1.17 1.36 1.356
Equity Multiplier -14.02 -21.23 -4.64 -2.72 -1.82 -6.89 -4.83 -2.95 -2.08 -3.92 -2.48 -2.52 -1.77 -1.26 -0.89 -0.86 -0.67 -0.57 -0.55 -0.38 -0.380
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $-2.73 $-1.43 $-1.39 $-1.30 $-1.10 $-1.84 $-20.89 $-1.24 $-18.33 $-18.70 $-19.01 $-8.73 $-10.50 $-9.11 $-7.38 $-14.33 $-14.38 $-10.90 $-7.89 $-7.77 $-7.77
Book Value/Share $-1.67 $-0.92 $-1.07 $-1.46 $-1.75 $-0.19 $-5.97 $-0.62 $-13.16 $-17.80 $-21.95 $-12.84 $-19.16 $-22.17 $-24.31 $-27.72 $-31.06 $-16.29 $-10.75 $-11.41 $-11.41
Tangible Book/Share $-1.67 $-0.92 $-1.07 $-1.46 $-1.75 $-0.19 $-5.97 $-0.62 $-13.16 $-17.80 $-21.95 $-12.84 $-19.16 $-22.17 $-24.31 $-27.72 $-31.06 $-16.29 $-10.75 $-11.41 $-11.41
Revenue/Share $1.57 $2.42 $3.02 $3.16 $3.11 $1.75 $19.58 $1.28 $19.13 $19.08 $18.25 $14.15 $17.81 $17.31 $16.78 $15.92 $16.44 $8.12 $6.11 $5.07 $5.07
FCF/Share $-2.16 $-1.24 $-1.47 $-1.17 $-1.22 $-1.66 $-14.44 $-0.87 $-13.23 $-12.12 $-15.30 $-12.68 $-14.45 $-15.21 $-14.49 $-11.94 $-10.30 $-4.19 $-2.39 $-2.26 $-2.26
OCF/Share $-2.16 $-1.23 $-1.46 $-1.17 $-1.21 $-1.66 $-14.44 $-0.87 $-13.24 $-12.12 $-15.27 $-12.66 $-14.43 $-15.19 $-14.49 $-11.94 $-10.31 $-4.19 $-2.39 $-2.26 $-2.26
Cash/Share $2.71 $2.63 $2.65 $2.14 $1.85 $3.09 $34.42 $2.07 $27.31 $25.02 $19.30 $14.78 $16.02 $12.95 $8.26 $6.00 $5.29 $3.55 $3.68 $2.25 $2.25
EBITDA/Share $-2.38 $-1.12 $-1.02 $-0.93 $-0.75 $-1.55 $-17.57 $-1.03 $-15.14 $-15.48 $-15.81 $-6.04 $-6.53 $-4.60 $-2.32 $-9.10 $-9.28 $-8.37 $-5.98 $-6.08 $-6.08
Debt/Share $2.40 $2.08 $2.32 $2.26 $2.24 $1.99 $23.61 $1.56 $23.28 $23.13 $22.92 $19.00 $23.31 $23.18 $22.04 $22.11 $22.66 $12.99 $9.34 $7.46 $7.46
Net Debt/Share $-0.31 $-0.55 $-0.32 $0.11 $0.39 $-1.10 $-10.81 $-0.51 $-4.03 $-1.89 $3.62 $4.23 $7.29 $10.23 $13.79 $16.12 $17.37 $9.45 $5.67 $5.21 $5.21
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — -27.070
Altman Z-Prime snapshot only -65.741
Piotroski F-Score 3 4 5 4 3 3 4 3 5 4 2 3 2 3 3 4 2 3 3 2 2
Beneish M-Score -3.04 -0.86 -1.67 -1.68 -2.18 2.19 -3.04 -3.09 -2.44 -2.85 -2.15 0.44 -1.56 -0.83 -0.08 -3.43 -4.05 -8.10 -7.80 -9.51 -9.515
Ohlson O-Score snapshot only 19.280
Net-Net WC snapshot only $-11.58
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only CCC
Credit Score 20.00 20.00 20.00 20.00 20.00 20.00 20.00 20.00 20.00 20.00 20.00 20.00 20.00 20.00 20.00 17.31 18.75 19.70 19.86 14.85 14.855
Credit Grade snapshot only 17
Credit Trend snapshot only -2.459
Implied Spread (bps) snapshot only 1200.000
Industry Credit Rank snapshot only 5
Sector Credit Rank snapshot only 5

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms